Literature DB >> 10725690

Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro.

P Chavalitshewinkoon-Petmitr1, G Pongvilairat, S Auparakkitanon, P Wilairat.   

Abstract

Gametocytocidal activities of pyronaridine and DNA topoisomerase II inhibitors against two isolates of multidrug-resistant Plasmodium falciparum, KT1 and KT3 were determined. After sorbitol treatment, pure gametocyte cultures of Plasmodium falciparum containing mostly young gametocytes (stage II and III) obtained on day 11 were exposed to the drugs for 48 h. The effect of the drugs on gametocyte development was assessed by counting gametocytes on day 15 of culture. Pyronaridine was the most effective gametocytocidal drug against P. falciparum isolates KT1 and KT3 with 50% inhibitory concentration of 6 and 20 nM, respectively. Moreover, the 50% inhibitory concentration of pyronaridine was lower than that of primaquine which is the only drug used to treat malaria patients harboring gametocytes. Prokaryotic (norfloxacin) and eukaryotic (amsacrine and etoposide) DNA topoisomerase II inhibitors were only effective against asexual but not sexual stages of the malaria parasites. Pyronaridine has both schizontocidal and gametocytocidal activities against the human malaria parasite, P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725690     DOI: 10.1016/s1383-5769(99)00028-8

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  19 in total

Review 1.  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.

Authors:  Rashad Abdul-Ghani; John C Beier
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

2.  Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation.

Authors:  Celia Miguel-Blanco; Joël Lelièvre; Michael J Delves; Ana I Bardera; Jesús L Presa; María José López-Barragán; Andrea Ruecker; Sara Marques; Robert E Sinden; Esperanza Herreros
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

Review 3.  Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Joseph Pryce; Melissa Taylor; Tilly Fox; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2022-06-21

4.  Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.

Authors:  Carola Huthmacher; Andreas Hoppe; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  BMC Syst Biol       Date:  2010-08-31

5.  Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay.

Authors:  Leonardo Lucantoni; Sandra Duffy; Sophie H Adjalley; David A Fidock; Vicky M Avery
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

Review 6.  Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Hasifa Bukirwa; B Unnikrishnan; Christine V Kramer; David Sinclair; Suma Nair; Prathap Tharyan
Journal:  Cochrane Database Syst Rev       Date:  2014-03-04

7.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

8.  Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine.

Authors:  Kanyanan Kritsiriwuthinan; Sastra Chaotheing; Philip J Shaw; Chayaphat Wongsombat; Porntip Chavalitshewinkoon-Petmitr; Sumalee Kamchonwongpaisan
Journal:  Malar J       Date:  2011-08-18       Impact factor: 2.979

9.  Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.

Authors:  Joël Lelièvre; Maria Jesus Almela; Sonia Lozano; Celia Miguel; Virginia Franco; Didier Leroy; Esperanza Herreros
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

10.  Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Joseph Pryce; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2019-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.